Skip to content
Politically.com Search all
Menu

2025 · 4th Quarter (Oct 1 - Dec 31)

AVADEL PHARMACEUTICALS, PLC

Filed by LMH STRATEGIC SOLUTIONS.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
4th Quarter - Report
Posted
Jan 12, 2026
Income
$60,000.00
Expenses
Not reported
Filing UUID
8fd0cf41-210c-47bb-8aa3-094f605335b9
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Prescription Drug Competition Issues. H.R.4692/S.574 - Increasing Prescription Drug Competition Act. VA Appropriations Request.

Literal federal measure citations: H.R.4692, S.574

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.